There are dozens of genes that effect how well a woman metabolizes and shares nutrition with her developing fetus or newborn. On average, 45% of women have inefficiencies in metabolism caused by key gene variants which do not allows for proper nutrition to be delivered to the baby from the mother.
Key 1-carbon nutrients such as choline, folate, b-12, betaine and DHA that may affect the brain, eye, and spinal cord development of their baby. The consequence for inefficiencies in these metabolic pathways includes diminished cognitive development and increased risk of neural tube defects.
SNP Therapeutcs has developed a genetic test based on a proprietary algorithm that can accurately predict the severity of nutrient blockages. It is working with top nutrition partners to target the 3.9M births each year in the United States.
The SNP Therapeutics prenatal genetic test report will help pregnant women address their need for increased nutrition across key nutrients and support our business partners to support their customer’s needs.